20-408636-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_031229.4(RBCK1):c.-122G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0377 in 1,322,684 control chromosomes in the GnomAD database, including 1,146 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.029 ( 88 hom., cov: 32)
Exomes 𝑓: 0.039 ( 1058 hom. )
Consequence
RBCK1
NM_031229.4 5_prime_UTR
NM_031229.4 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.872
Genes affected
RBCK1 (HGNC:15864): (RANBP2-type and C3HC4-type zinc finger containing 1) Enables several functions, including identical protein binding activity; protein sequestering activity; and ubiquitin binding activity. Involved in several processes, including T cell receptor signaling pathway; cellular protein metabolic process; and regulation of DNA-binding transcription factor activity. Part of LUBAC complex. Implicated in glycogen storage disease. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 20-408636-G-A is Benign according to our data. Variant chr20-408636-G-A is described in ClinVar as [Benign]. Clinvar id is 1255114.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-408636-G-A is described in Lovd as [Likely_benign].
BA1
GnomAdExome4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0503 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBCK1 | NM_031229.4 | c.-122G>A | 5_prime_UTR_variant | 1/12 | ENST00000356286.10 | NP_112506.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBCK1 | ENST00000356286 | c.-122G>A | 5_prime_UTR_variant | 1/12 | 1 | NM_031229.4 | ENSP00000348632.6 |
Frequencies
GnomAD3 genomes AF: 0.0293 AC: 4467AN: 152244Hom.: 88 Cov.: 32
GnomAD3 genomes
AF:
AC:
4467
AN:
152244
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0388 AC: 45410AN: 1170322Hom.: 1058 Cov.: 16 AF XY: 0.0393 AC XY: 23092AN XY: 587902
GnomAD4 exome
AF:
AC:
45410
AN:
1170322
Hom.:
Cov.:
16
AF XY:
AC XY:
23092
AN XY:
587902
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0293 AC: 4464AN: 152362Hom.: 88 Cov.: 32 AF XY: 0.0292 AC XY: 2173AN XY: 74506
GnomAD4 genome
AF:
AC:
4464
AN:
152362
Hom.:
Cov.:
32
AF XY:
AC XY:
2173
AN XY:
74506
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
62
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 23, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at